http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109071588-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7072 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7072 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-10 |
filingDate | 2017-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-109071588-B |
titleOfInvention | Uridine phosphamide prodrug, preparation method and application thereof in medicine |
abstract | The invention relates to a uridine phosphoramide prodrug, a preparation method thereof and application thereof in medicine, wherein the prodrug is a compound shown as a general formula I or an optical isomer thereof or a pharmaceutically acceptable salt thereof, the prodrug also comprises a solvate of the compound shown as the general formula I or the optical isomer thereof or the pharmaceutically acceptable salt thereof, and the prodrug can be used for treating virus infectious diseases, particularly hepatitis C virus infectious diseases. |
priorityDate | 2016-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 127.